Conference Recap Issue: 2023 American Society of Clinicial Oncology Annual Meeting
ASCO 2023: From Our Partners
Coverage of research presented by Strategic Alliance Partners: OneOncology, Florida Cancer Specialists & Research Institute, and The US Oncology Network.
ASCO 2023: Payment Models and Policy
Coverage of ASCO sessions and posters that addressed lessons from the Oncology Care Model and concerns about the Enhancing Oncology Model, which launched shortly after the annual meeting ended.
ASCO 2023: Health Equity
Coverage of sessions on disparities in access to clinical trials and cancer screening, as well as relationships each to outcomes. A joint session presented by ASCO and the European Society for Medical Oncology (ESMO) highlighted progress and lingering gaps in lung and colorectal screening.
ASCO 2023: Multiple Myeloma
Results included those for several bispecifics, used as monotherapy and in combination, including early results for 2 bispecifics used together.
ASCO 2023: Myelodysplastic Syndromes
Presentation of the COMMANDS trial offered practice-changing results for luspatercept.
ASCO 2023: Leukemia and Lymphoma
Results include a landmark study that involved seamless collaboration across adult and pediatric patient groups, leading to a highly diverse study population. Other coverage addresses access to novel therapies and what's coming in the pipeline, including CAR T-cell therapy with tyrosine kinase inhibitors.
ASCO 2023: Solid Tumors
Coverage of clinical trial results presented across a range of solid tumor cancers, including breast, ovarian, colorectal, and non-small cell lung cancer, among other types; as well as important findings in genomic testing.
ASCO 2023: Opening Session
Coverage of addresses by ASCO President Eric P. Winer, MD, and National Cancer Institute Director Monica M. Bertagnolli, MD, who is a former ASCO president.
2 Clarke Drive Cranbury, NJ 08512